X Bioscience PCL (BKK:XBIO)
0.1100
0.00 (0.00%)
Last updated: Apr 22, 2025
X Bioscience PCL Revenue
In the year 2024, X Bioscience PCL had annual revenue of 319.24M THB with 2.40% growth. X Bioscience PCL had revenue of 98.85M in the quarter ending December 31, 2024, with 29.12% growth.
Revenue
319.24M
Revenue Growth
+2.40%
P/S Ratio
0.72
Revenue / Employee
800.11K
Employees
399
Market Cap
230.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 319.24M | 7.47M | 2.40% |
Dec 31, 2023 | 311.77M | -32.71M | -9.50% |
Dec 31, 2022 | 344.49M | 90.44M | 35.60% |
Dec 31, 2021 | 254.04M | -161.57M | -38.88% |
Dec 31, 2020 | 415.62M | -9.03M | -2.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CP ALL PCL | 987.14B |
CP Axtra PCL | 508.75B |
Charoen Pokphand Foods PCL | 583.57B |
Thai President Foods PCL | 29.77B |
Carabao Group PCL | 19.65B |
Osotspa PCL | 27.08B |
Thai Union Group PCL | 138.43B |
Betagro PCL | 114.83B |